London and the South East – A Global Centre for Life Sciences.

London, together with Oxford and Cambridge, conducts world class biomedical research to rival any cluster in the world. Our challenge is to promote that capability and secure the industrial engagement and financial support to translate science to benefit UK health and wealth.

Building on a history of increasing collaboration between UCLPartners, King’s Health Partners, Imperial College Academic Health Science Centre, Oxford and Cambridge, MedCity provides the vehicle to realise that ambition, ensuring London and the Greater South East become the premier global hub for the development of novel therapeutics, devices and diagnostics to address medical need.

UCL at MedCity

UCL has remarkable capability across 5 therapeutic innovation networks, reflecting major therapeutic modalities and diagnostic innovation (imaging, genomics, and molecular pathology).

  1. Small molecules
  2. Biologics
  3. Cell and Gene therapy
  4. Devices
  5. Diagnostics


UCL is highly experienced in partnership working across disciplinary and organisational boundaries.

Find out more about opportunities for commercial partners with UCL and UCLPartners Academic Health Science Centre through our dedicated Translational Research Office

MedCity Logo